EP Patent

EP1157692B1 — Composition of fatty acids containing at least 80% by weight of EPA and DHA or their derivatives and its pharmaceutical use

Assigned to Pro Aparts - Investimentos E Consultoria Lda · Expires 2005-10-05 · 21y expired

What this patent protects

There is described a composition of fatty acids containing at least 80% by weight of acid 5,8,11,14,17-eicosapentaenoic acid (EPA) C20 : 5 omega -3 ( double bonds all cis) and acid 4,7,10,13,16,19-docosaexaenoic acid (DHA) C22:6 omega -3 (double bonds all cis), where the ratio …

USPTO Abstract

There is described a composition of fatty acids containing at least 80% by weight of acid 5,8,11,14,17-eicosapentaenoic acid (EPA) C20 : 5 omega -3 ( double bonds all cis) and acid 4,7,10,13,16,19-docosaexaenoic acid (DHA) C22:6 omega -3 (double bonds all cis), where the ratio EPA:DHA is within 0.9 and 1.5 and other omega -3 acids C20, C21 and C22 constitute less than 3% and where such acids may be present in the form of free acids or their salts or other derivatives pharmaceutically acceptable and a process for the preparation thereof. The compositions of the invention are useful for the production of a pharmaceutical preparation for the treatment and/or prophylaxis of multiple risk factors for cardiovascular diseases and/or other pathologies sensitive to the action of EPA and DHA.

Drugs covered by this patent

Patent Metadata

Patent number
EP1157692B1
Jurisdiction
EP
Classification
Expires
2005-10-05
Drug substance claim
No
Drug product claim
No
Assignee
Pro Aparts - Investimentos E Consultoria Lda
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.